STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Universe Pharmaceuticals Inc SEC Filings

UPC NASDAQ

Welcome to our dedicated page for Universe Pharmaceuticals SEC filings (Ticker: UPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Universe Pharmaceuticals’ blend of Traditional Chinese Medicine and modern biomedicine creates filings dense with dual-framework manufacturing data, supply-chain disclosures, and cross-border quality standards. If you’ve searched a 300-page 10-K trying to separate TCM revenue from OTC cold remedies, you know the challenge. Stock Titan eliminates that pain: our AI ingests every submission the moment it hits EDGAR and surfaces the numbers, risks, and segment details investors look for first.

Want Universe Pharmaceuticals insider trading Form 4 transactions before the market reacts? We stream them in real time. Need the latest Universe Pharmaceuticals quarterly earnings report 10-Q filing or a headline-moving 8-K? Each document arrives here with an AI-powered summary that turns technical language into plain English—truly Universe Pharmaceuticals SEC filings explained simply. You’ll also find the full proxy—Universe Pharmaceuticals proxy statement executive compensation—alongside Universe Pharmaceuticals Form 4 insider transactions real-time alerts, ensuring nothing slips past you.

Because the company leans on both proprietary production and third-party suppliers, its disclosures uncover margins by product class, herbal sourcing data, and regulatory milestones. Use this page to:

  • Run a Universe Pharmaceuticals earnings report filing analysis with AI-generated trend tables.
  • Compare cash flows across segments through the Universe Pharmaceuticals annual report 10-K simplified.
  • Monitor sentiment via Universe Pharmaceuticals executive stock transactions Form 4.
  • See Universe Pharmaceuticals 8-K material events explained within minutes of filing.
  • Start understanding Universe Pharmaceuticals SEC documents with AI instead of reading page by page.

All filings, all forms, always current—backed by real-time updates and expert-level AI summaries that make due diligence fast and clear.

Rhea-AI Summary

Universe Pharmaceuticals Inc. reported the results of shareholder votes on corporate proposals. Five directors — Gang Lai, Lin Yang, Jiawen Pang, Ding Zheng and Yongping Yu — were re-elected, each receiving strong majority support, with two directors above 94.2% and the others ranging around 89.6%-89.9%. A special resolution to adopt an amended and restated memorandum and articles of association (the A&R M&A) following a proposed Capital Reorganisation received 74.74% support. An ordinary resolution to adjourn the meeting if needed received 77.79% support. The report lists vote percentages for each proposal, showing broadly high director support and a lower but positive vote for the A&R M&A.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Universe Pharmaceuticals (UPC)?

The current stock price of Universe Pharmaceuticals (UPC) is $3.43 as of November 24, 2025.

What is the market cap of Universe Pharmaceuticals (UPC)?

The market cap of Universe Pharmaceuticals (UPC) is approximately 1.9M.
Universe Pharmaceuticals Inc

NASDAQ:UPC

UPC Rankings

UPC Stock Data

1.92M
559.87k
0.62%
3.95%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
China
Ji'An